Acute aortic dissection in a hypertensive patient with prostate cancer undergoing chemotherapy containing bevacizumab.
Aragon-Ching
Jeanny B
JB
Medical Oncology Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Ning
Yang-Min
YM
Dahut
William L
WL
D000368:Aged; D000784:Aortic Dissection / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D001014:Aortic Aneurysm / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D000068258:Bevacizumab; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000601:surgery; D014057:Tomography, X-Ray Computed; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab